TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2025

Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up results.

Daniel Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.